Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide for Prevention of Salivary Fistulae After Salvage Surgery
NCT02437825Phase 2Unknown
- Sponsor
- Hadassah Medical Organization
- Start
- Oct 2015
- Primary completion
- Jun 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of octreotide in Salivary gland fistula, sponsored by Hadassah Medical Organization. Status: unknown.
02
Drugs
octreotide
03
Conditions
Salivary gland fistula
Beyond the preview
Go deeper on NCT02437825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02437825.